Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
2011

Galectin-3 Levels and Heart Failure Prognosis

Sample size: 592 publication 10 minutes Evidence: high

Author Information

Author(s): Rudolf A de Boer, Dirk J A Lok, Tiny Jaarsma, Peter van der Meer, Adriaan A Voors, Hans L Hillege, Dirk J van Veldhuisen

Primary Institution: University Medical Centre Groningen

Hypothesis

The study investigates the prognostic value of baseline galectin-3 levels in heart failure patients with both reduced and preserved ejection fraction.

Conclusion

Galectin-3 is an independent marker for outcome in heart failure and is particularly useful in patients with preserved ejection fraction.

Supporting Evidence

  • A doubling of galectin-3 levels was associated with a hazard ratio of 1.97 for the primary outcome.
  • Galectin-3 levels were correlated with higher IL-6 and CRP levels.
  • The predictive value of galectin-3 was stronger in patients with preserved LVEF compared to those with reduced LVEF.

Takeaway

Galectin-3 is a blood marker that helps doctors understand how serious heart failure is, especially in older patients whose hearts still pump well.

Methodology

The study followed 592 hospitalized heart failure patients for 18 months, measuring baseline galectin-3 levels and comparing them to other biomarkers.

Limitations

The study's findings are limited by the small number of patients with preserved ejection fraction and the lack of standardized echocardiographic evaluation.

Participant Demographics

Mean age was 72 years, with 65% male; half were in NYHA class III and IV.

Statistical Information

P-Value

<0.001

Confidence Interval

1.62–2.42

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.3109/07853890.2010.538080

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication